Chemical genetics: Tailoring tools for cell biology

Trends in Cell Biology

Volumn 13, Issue 5, 2003, Pages 270-277

  Mayer, Thomas U ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPURVALANOL; FUMAGILLIN; ILIMAQUINONE; LACTACYSTIN; PURVALANOL; QUINONE DERIVATIVE; RAPAMYCIN; UNCLASSIFIED DRUG;

ACCURACY; CELL FUNCTION; CHEMICAL GENETICS; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TARGET CELL;

EID: 0038400185     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(03)00077-1     Document Type: Review

References (66)

1. Hartwell L.H. Twenty-five years of cell cycle genetics. Genetics. 129:1991;975-980.
2. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 77:1974;71-94.
3. Nusslein-Volhard C., Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 287:1980;795-801.
4. Bishop A., et al. Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu. Rev. Biophys. Biomol. Struct. 29:2000;577-606.
5. Klausner R.D., et al. Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116:1992;1071-1080.
6. Brinkley B.R., et al. The effects of colcemid inhibition and reversal on the fine structure of the mitotic apparatus of Chinese hamster cells in vitro. J. Ultrastruct. Res. 19:1967;1-18.
7. Borisy G.G., Taylor E.W. The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein. J. Cell Biol. 34:1967;525-533.
8. Avila J. Microtubule functions. Life Sci. 50:1992;327-334.
9. Khayat D., et al. Taxol in the management of cancers of the breast and the ovary. Cancer Invest. 18:2000;242-260.
10. Schiff P.B., et al. Promotion of microtubule assembly in vitro by taxol. Nature. 277:1979;665-667.
11. Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U. S. A. 77:1980;1561-1565.
12. Vallee R.B. A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs). J. Cell Biol. 92:1982;435-442.
13. Cohn S.A., et al. Analyzing microtubule motors in real time. Methods Cell Biol. 39:1993;75-88.
14. Dolle R.E. Comprehensive survey of combinatorial library synthesis: 2001. J. Comb. Chem. 4:2002;369-418.
15. On the World Wide Web URL: http://www.combichem.net .
16. Muegge I. Pharmacophore features of potential drugs. Chemistry. 8:2002;1976-1981.
17. On the World Wide Web URL: http://dtp.nci.nih.gov/webdata.html, http://www.ninds.nih.gov/funding/neurodegeneration/NINDS_Drug_Screening.htm, http://www.hki-jena.de/hki_hp.htm .
18. Hertzberg R.P., Pope A.J. High-throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4:2000;445-451.
19. Stockwell B.R., et al. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6:1999;71-83.
20. Boland M.V., et al. Automated recognition of patterns characteristic of subcellular structures in fluorescence microscopy images. Cytometry. 33:1998;366-375.
21. Peterson R.T., et al. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12965-12969.
22. Rosania G.R., et al. Myoseverin, a microtubule-binding molecule with novel cellular effects. Nat. Biotechnol. 18:2000;304-308.
23. Pelish H.E., et al. Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. J. Am. Chem. Soc. 123:2001;6740-6741.
24. Mitchison T.J. Towards a pharmacological genetics. Chem. Biol. 1:1994;3-6.
25. Tanaka A.S., et al. Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors. FEBS Lett. 458:1999;11-16.
26. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763.
27. Licitra E.J., Liu J.O. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12817-12821.
28. Giaever G., et al. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 21:1999;278-283.
29. Launhardt H., et al. Drug-induced phenotypes provide a tool for the functional analysis of yeast genes. Yeast. 14:1998;935-942.
30. Wignall S.M., et al. A chemistry-based approach to identify regulators of spindle assembly: Characterization of a microtubule destabilizing compound and target identification. Mol. Biol. Cell. 11:2000;361a.
31. Casaubon R.L., Snapper M.L. S-adenosylmethionine reverses ilimaquinone's vesiculation of the Golgi apparatus: a fluorescence study on the cellular interactions of ilimaquinone. Bioorg. Med. Chem. Lett. 11:2001;133-136.
32. Rosania G.R., et al. A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4797-4802.
33. Butte A. The use and analysis of microarray data. Nat. Rev. Drug Discov. 1:2002;951-960.
34. Marton M.J., et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4:1998;1293-1301.
35. Li R., Murray A.W. Feedback control of mitosis in budding yeast. Cell. 66:1991;519-531.
36. Hoyt M.A., et al. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell. 66:1991;507-517.
37. Crews C.M., Mohan R. Small-molecule inhibitors of the cell cycle. Curr. Opin. Chem. Biol. 4:2000;47-53.
38. Theesfeld C.L., et al. The role of actin in spindle orientation changes during the Saccharomyces cerevisiae cell cycle. J. Cell Biol. 146:1999;1019-1032.
39. Peterson J.R., Mitchison T.J. Small molecules, big impact. A history of chemical inhibitors and the cytoskeleton. Chem. Biol. 9:2002;1275-1285.
40. Bedalov A., et al. Identification of a small molecule inhibitor of Sir2p. Proc. Natl. Acad. Sci. U. S. A. 98:2001;15113-15118.
41. Mayer T.U., et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science. 286:1999;971-974.
42. Straight A.F., et al. Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science. 299:2003;1743-1747.
43. Blangy A., et al. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell. 83:1995;1159-1169.
44. Kapoor T.M., et al. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J. Cell Biol. 150:2000;975-988.
45. Kapoor T.M., Mitchison T.J. Eg5 is static in bipolar spindles relative to tubulin: evidence for a static spindle matrix. J. Cell Biol. 154:2001;1125-1133.
46. Waters J.C., et al. Localization of Mad2 to kinetochores depends on microtubule attachment, not tension. J. Cell Biol. 141:1998;1181-1191.
47. Jiang X., et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science. 299:2003;223-226.
48. Dinter A., Berger E.G. Golgi-disturbing agents. Histochem. Cell Biol. 109:1998;571-590.
49. McDowell W., Schwarz R.T. Dissecting glycoprotein biosynthesis by the use of specific inhibitors. Biochimie. 70:1988;1535-1549.
50. Stockwell B.R. Chemical genetic screening approaches to neurobiology. Neuron. 36:2002;559-562.
51. Ward G.E., et al. Using small molecules to study big questions in cellular microbiology. Cell Microbiol. 4:2002;471-482.
52. Holt J.R., et al. A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells. Cell. 108:2002;371-381.
53. Berg T., et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3830-3835.
54. Degterev A., et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat. Cell Biol. 3:2001;173-182.
55. Cheung A., et al. A small-molecule inhibitor of skeletal muscle myosin II. Nat. Cell Biol. 4:2002;83-88.
56. Dudley D.T., et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7686-7689.
57. Komarov P.G., et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 285:1999;1733-1737.
58. Tian S.S., et al. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science. 281:1998;257-259.
59. Haggarty S.J., et al. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem. Biol. 7:2000;275-286.
60. Meng L., et al. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res. 59:1999;2798-2801.
61. Sin N., et al. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6099-6103.
62. Radeke H.S., Snapper M.L. Photoaffinity study of the cellular interactions of ilimaquinone. Bioorg. Med. Chem. 6:1998;1227-1232.
63. Taunton J., et al. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 272:1996;408-411.
64. Fenteany G., et al. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:1995;726-731.
65. Harding M.W., et al. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341:1989;758-760.
66. Ab-Obeidi F., et al. Peptide and peptidomimetic libraries. Molecular diversity and drug design. Mol. Biotechnol. 9:1998;205-223.